Analyst Rating Changes — Upgrades, Downgrades & Price Targets

46577 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Sep 10 00:58 UTC	POR Portland General Electric	◎ Target	JPMorgan Chase & Co.	Aidan Kelly ★★★☆☆ #1924	Neutral	$56.00→ $53.00-5.4%
Sep 10 00:58 UTC	PLCE Children's Place	◎ Target	UBS Group	Jay Sole ★★★☆☆ #2211	Neutral	$4.00→ $3.25-18.8%
Sep 10 00:58 UTC	PII Polaris	◎ Target	Citigroup	James Hardiman ★★☆☆☆ #2498	Neutral	$73.00→ $67.00-8.2%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Morgan Stanley	Maxwell Skor ★★☆☆☆ #2838	Overweight	$46.00→ $62.00+34.8%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Leerink Partners	Joseph Schwartz ★★★★☆ #595	Outperform	$50.00→ $65.00+30.0%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Wells Fargo & Company	Yanan Zhu ★★★☆☆ #1662	Overweight	$55.00→ $65.00+18.2%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Citizens Jmp	Jonathan Wolleben ★★★★☆ #324	Market Outperform	$75.00→ $79.00+5.3%
Sep 10 00:58 UTC	PHVS Pharvaris	◎ Target	Royal Bank Of Canada	Nevin Varghese not yet tracked	Outperform	$52.00→ $62.00+19.2%
Sep 10 00:58 UTC	PDM Piedmont Realty Trust	◎ Target	JPMorgan Chase & Co.	Anthony Paolone ★★★☆☆ #1018	Neutral	$10.00→ $11.00+10.0%
Sep 10 00:58 UTC	PAYX Paychex	◎ Target	Wells Fargo & Company	Jason Kupferberg ★★☆☆☆ #2632	Underweight	$95.00→ $111.00+16.8%
Sep 10 00:58 UTC	PAYX Paychex	◎ Target	Stifel Nicolaus	David Grossman ★★★★☆ #967	Hold	$110.00→ $130.00+18.2%
Sep 10 00:58 UTC	PAGE PageGroup	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Buy	GBX 210→ GBX 355+69.0%
Sep 10 00:58 UTC	ORCL Oracle	◎ Target	Scotiabank	Patrick Colville ★★★★☆ #587	Sec→ r Outperform	$241.00→ $215.00-10.8%
Sep 10 00:58 UTC	ORA Ormat Technologies	◎ Target	JPMorgan Chase & Co.	Mark Strouse ★★☆☆☆ #2656	Neutral	$122.00→ $131.00+7.4%
Sep 10 00:58 UTC	ORA Ormat Technologies	◎ Target	Oppenheimer	Noah Kaye ★★★★☆ #536	Outperform	$141.00→ $145.00+2.8%
Sep 10 00:58 UTC	OKE ONEOK	◎ Target	Morgan Stanley	Robert Kad ★★★☆☆ #1998	Equal Weight	$105.00→ $112.00+6.7%
Sep 10 00:58 UTC	OGE OGE Energy	◎ Target	JPMorgan Chase & Co.	Aidan Kelly ★★★☆☆ #1924	Overweight	$55.00→ $54.00-1.8%
Sep 10 00:58 UTC	ODD ODDITY Tech	◎ Target	Jefferies Financial Group	Brian Tanquilut ★★★★☆ #751	Hold	$16.00→ $18.00+12.5%
Sep 10 00:58 UTC	NWE NorthWestern	◎ Target	JPMorgan Chase & Co.	Aidan Kelly ★★★☆☆ #1924	Neutral	$76.00→ $73.00-3.9%
Sep 10 00:58 UTC	NUE Nucor	◎ Target	JPMorgan Chase & Co.	Bennett Moore ★★☆☆☆ #2299	Overweight	$294.00→ $308.00+4.8%
Sep 10 00:58 UTC	NTRA Natera	◎ Target	UBS Group	Doug Schenkel not yet tracked	Buy	$290.00→ $435.00+50.0%
Sep 10 00:58 UTC	NTLA Intellia Therapeutics	◎ Target	Wedbush	David Nierengarten ★★★☆☆ #2163	Neutral	$12.00→ $13.00+8.3%
Sep 10 00:58 UTC	NEM Newmont	◎ Target	Sanford C. Bernstein	Bob Brackett ★★★★★ #296	Outperform	$147.00→ $144.00-2.0%
Sep 10 00:58 UTC	MRVI Maravai LifeSciences	◎ Target	UBS Group	Dan Brennan not yet tracked	Neutral	$2.50→ $8.00+220.0%
Sep 10 00:58 UTC	MRK Merck & Co., Inc.	◎ Target	Leerink Partners	Daina Graybosch ★★★★☆ #515	Outperform	$127.00→ $161.00+26.8%
Sep 10 00:58 UTC	MAB1 Mortgage Advice Bureau	◎ Target	Berenberg Bank	firm only	Buy	GBX 1,150→ GBX 975-15.2%
Sep 10 00:58 UTC	LULU lululemon athletica	◎ Target	Citigroup	Paul Lejuez ★★★☆☆ #1049	Neutral	$130.00→ $117.00-10.0%
Sep 10 00:58 UTC	LOW Lowe's Companies	◎ Target	Sanford C. Bernstein	Zhihan Ma ★★☆☆☆ #2556	Outperform	$261.00→ $254.00-2.7%
Sep 10 00:58 UTC	LFST LifeStance Health Group	◎ Target	Canaccord Genuity Group	Richard Close ★★★☆☆ #1303	Buy	$13.00→ $15.00+15.4%
Sep 10 00:58 UTC	KNF Knife River	◎ Target	Wells Fargo & Company	Timna Tanners ★★☆☆☆ #2728	Equal Weight	$73.00→ $62.00-15.1%
Sep 10 00:58 UTC	JSG Johnson Service Group	◎ Target	Berenberg Bank	firm only	Buy	GBX 205→ GBX 200-2.4%
Sep 10 00:58 UTC	JILL J.Jill	◎ Target	BTIG Research	Janine Stichter ★★★☆☆ #1915	Buy	$18.00→ $25.00+38.9%
Sep 10 00:58 UTC	IVN Ivanhoe Mines	◎ Target	Scotia	firm only	Sec→ r Perform	C$13.00→ C$13.50+3.8%
Sep 10 00:58 UTC	IVN Ivanhoe Mines	◎ Target	Canaccord Genuity Group	firm only	Buy	C$13.00→ C$15.00+15.4%
Sep 10 00:58 UTC	IVN Ivanhoe Mines	◎ Target	Stifel Nicolaus	firm only	Buy	C$15.00→ C$17.00+13.3%
Sep 10 00:58 UTC	IRD Opus Genetics	◎ Target	Chardan Capital	Andreas Argyrides ★★★☆☆ #1580	Buy	$13.00→ $16.00+23.1%
Sep 10 00:58 UTC	IRD Opus Genetics	◎ Target	Oppenheimer	Andreas Argyrides ★★★☆☆ #1580	Outperform	$10.00→ $20.00+100.0%
Sep 10 00:58 UTC	IONS Ionis Pharmaceuticals	◎ Target	Barclays	Eliana Merle ★★★☆☆ #1910	Overweight	$90.00→ $85.00-5.6%
Sep 10 00:58 UTC	IONQ IonQ	◎ Target	Mizuho	Vijay Rakesh ★★☆☆☆ #2588	Outperform	$61.00→ $52.00-14.8%
Sep 10 00:58 UTC	INNV InnovAge	◎ Target	KeyCorp	Matthew Gillmor not yet tracked	Overweight	$13.00→ $14.00+7.7%
Sep 10 00:58 UTC	IMAX IMAX	◎ Target	Rosenblatt Securities	Steve Frankel ★★☆☆☆ #2655	Buy	$60.00→ $65.00+8.3%
Sep 10 00:58 UTC	IEX IDEX	◎ Target	Oppenheimer	Bryan Blair ★★★★☆ #777	Outperform	$265.00→ $270.00+1.9%
Sep 10 00:58 UTC	IDYA IDEAYA Biosciences	◎ Target	Guggenheim	Paul Jeng ★☆☆☆☆ #2910	Buy	$54.00→ $57.00+5.6%
Sep 10 00:58 UTC	HOOD Robinhood Markets	◎ Target	Mizuho	Dan Dolev ★★★☆☆ #1358	Outperform	$130.00→ $140.00+7.7%
Sep 10 00:58 UTC	HLN Haleon	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Sell	GBX 335→ GBX 320-4.5%
Sep 10 00:58 UTC	HD Home Depot	◎ Target	Sanford C. Bernstein	Zhihan Ma ★★☆☆☆ #2556	Market Perform	$354.00→ $344.00-2.8%
Sep 10 00:58 UTC	HASI HA Sustainable Infrastructure Capital	◎ Target	Mizuho	Maheep Mandloi ★★☆☆☆ #2857	Outperform	$41.00→ $50.00+22.0%
Sep 10 00:58 UTC	HAS Hays	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Buy	GBX 60→ GBX 95+58.3%
Sep 10 00:58 UTC	GH Guardant Health	◎ Target	UBS Group	Dan Leonard ★★★★☆ #383	Buy	$175.00→ $225.00+28.6%
Sep 10 00:58 UTC	GEMI Gemini Space Station	◎ Target	The Goldman Sachs Group	James Yaro ★★☆☆☆ #2427	Sell	$3.50→ $4.00+14.3%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!